Search research articles
Contact Us
Filters
Showing results (221-230 of 230) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 230 results.
Journal of Crohn'S & Colitis
|
October 6, 2017
Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease
María José Casanova, Maria Chaparro, Begoña Molina, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
Journal of Crohn'S & Colitis
|
April 16, 2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
María Chaparro, Ana Garre, Marisa Iborra, et al.
United European Gastroenterology Journal
|
December 6, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
Míriam Mañosa, Margalida Calafat, Elena Ricart, et al.
Journal of Crohn'S & Colitis
|
May 8, 2019
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Ivan Guerra, Luis Bujanda, Jesús Castro, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Alimentary Pharmacology & Therapeutics
|
September 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
María Chaparro, Sandra Hermida, Diana Acosta, et al.
Journal of Clinical Medicine
|
July 2, 2021
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Journal of Clinical Medicine
|
October 14, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2885
María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 230) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 230 results.
Journal of Crohn'S & Colitis
|
October 6, 2017
Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel Disease
María José Casanova, Maria Chaparro, Begoña Molina, et al.
The American Journal of Gastroenterology
|
January 30, 2023
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
María Chaparro, Diana Acosta, Cristina Rodríguez, et al.
Journal of Crohn'S & Colitis
|
April 16, 2021
Effectiveness and Safety of Ustekinumab in Ulcerative Colitis: Real-world Evidence from the ENEIDA Registry
María Chaparro, Ana Garre, Marisa Iborra, et al.
United European Gastroenterology Journal
|
December 6, 2025
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
Míriam Mañosa, Margalida Calafat, Elena Ricart, et al.
Journal of Crohn'S & Colitis
|
May 8, 2019
Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study
Ivan Guerra, Luis Bujanda, Jesús Castro, et al.
Alimentary Pharmacology & Therapeutics
|
August 8, 2025
Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
Cristina Rubín de Célix, Elena Ricart, M Dolores Martín-Arranz, et al.
Alimentary Pharmacology & Therapeutics
|
June 29, 2024
Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry
Rocío Ferreiro-Iglesias, Sol Porto Silva, Sandra Marín, et al.
Alimentary Pharmacology & Therapeutics
|
September 17, 2024
Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
María Chaparro, Sandra Hermida, Diana Acosta, et al.
Journal of Clinical Medicine
|
July 2, 2021
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Journal of Clinical Medicine
|
October 14, 2022
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. <i>J. Clin. Med.</i> 2021, <i>10</i>, 2885
María Chaparro, Ana Garre, Andrea Núñez Ortiz, et al.
Page
of 23